
Contact
Initial investment phase
Series A/B+
Initial investment size
€500k to €2.5m
Partnering with the best.

Blueprint Genetics
Helsinki/Finland
Blueprint Genetic supports health care professionals worldwide in finding the best care for patients and families with rare inherited diseases through AI-enabled clinical genetic DNA testing.
Homepage

CryoTherapeutics
Awans/Belgium
CryoTherapeutics develops a revolutionary cardiovascular catheter system for the treatment of unstable non-stenotic lesions in coronary heart vessels, thereby significantly reducing the need for stenting.
Homepage

Klara
New York/USA
Klara is the secure healthcare communication platform, revolutionizing healthcare communication for everyone involved in the patient's journey.
Homepage

Phenex Pharmaceuticals
Ludwigshafen/Germany
Phenex is a world-renowned drug discovery and development company focused on the target class of nuclear receptors for the development of novel pharmaceuticals.
Homepage

Prostatype Genomics
Solna/Sweden
Prostatype Genemocs develops and commercializes the molecular diagnostic test “Prostatype™” to stratify prostate cancer patients into risk categories and provide decision support when making a treatment decision.
Homepage

SIRION Biotech
Martinsried/Germany
SIRION is a supplier of sophisticated viral vectors that are being used for gene function research, preclinical target validation, gene therapy and vaccine development.
Homepage
Updates and opinions.